(Q51487246)

5 April 2018

title

Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome. (English)

1 reference

5 April 2018

polycystic ovary syndrome

main subject

obesity

0 references

1 reference

1 reference

1

1 reference

5 April 2018

Lisa J Moran

3

1 reference

5 April 2018

Peter M. Clifton

5

1 reference

5 April 2018

author name string

Noakes M

2

1 reference

5 April 2018

Norman R

4

1 reference

5 April 2018

publication date

1 November 2006

1 reference

5 April 2018

BJOG: an International Journal of Obstetrics and Gynaecology

published in

1 reference

5 April 2018

volume

113

1 reference

5 April 2018

page(s)

1308-1314

1 reference

5 April 2018

issue

11

1 reference

5 April 2018

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Cardiovascular consequences of polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Polycystic ovary syndrome and cardiovascular disease: a premature association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Mortality of women with polycystic ovary syndrome at long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Cardiovascular risk in women with polycystic ovarian syndrome (PCOS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Polycystic ovary syndrome is associated with endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Predictors of endothelial dysfunction in young women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Gender difference in age-related changes in vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Vascular dysfunction and metabolic parameters in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Metformin administration improves endothelial function in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Endothelial dysfunction in endocrine disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Evidence-based guidelines for cardiovascular disease prevention in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Relationship between serum sex hormones and coronary artery disease in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Sex hormone levels and risk of cardiovascular events in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Endogenous postmenopausal hormones and carotid atherosclerosis: a case-control study of the atherosclerosis risk in communities cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Evidence that parenteral testosterone therapy may improve endothelium-dependent and -independent vasodilation in postmenopausal women already receiving estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Inflammatory bio-markers and cardiovascular risk prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

Low grade chronic inflammation in women with polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2006.01090.X

10.1111/J.1471-0528.2006.01090.X

21 January 2018

Identifiers

DOI

1 reference

5 April 2018

release_2am2xlyy4ja7hhgimgafoajyg4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2am2xlyy4ja7hhgimgafoajyg4

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

17059392

1 reference

5 April 2018